Factory CRO and Boston Biomedical Associates Merge

Factory-CRO Group, a global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs), and Boston Biomedical Associates (BBA), a full-service medical device/biotechnology CRO and consultancy based in the United States announce that they have merged the organizations.   The merger further advances the shared strategic vision to become the leading Global Medical Device and Medical Technology focused CRO. Following the recent acquisitions of MileStone Research Organization, Five Corners, and Clinical Device Group the Factory-CRO Group now has specialized operations and expertise in the United States, Australia/New Zealand, and Europe. This global expansion coupled with the diverse medical therapeutic expertise provides a means to efficiently service clients.   “BBA is excited to join Factory-CRO’s worldwide group as it will allow us to expand our comprehensive service offering to our clients,” said Lauren Baker, PhD, president and CEO of BBA. “The alignment of Factory-CRO and BBA’s core values and approach to engagements combined with our collective therapeutic competencies ensures that our clients now have improved access to our global clinical trial execution resources, and our regulatory and medical expertise.”   Dr. Baker then added, “We are able to fully support our clients as their needs evolve and they strive to help patients globally.”   “We are honored to have the BBA team join the Factory-CRO Group,” said Dirk Meijer, MD, MSc, PhD, Factory-CRO CEO. “BBA’s ability to provide CRO/Consultative service in North America was a missing link in our global offerings.” Dr. Meijer then added, “Our clients have consistently asked us to expand our offerings in North America. This merger allows us to provide our specialized expertise and a continued commitment to the highest level of customized service to a larger audience. Now we are the only medical device and medical technology CRO that offers services in United States, Europe, Australia, and New Zealand. We operate from our own offices located within each region housed with employees that have refined expertise to meet our unique client needs.”